Commitments and Contingencies (Details) - AbbVie Biotherapeutics Corp [Member] - USD ($) |
9 Months Ended | |
---|---|---|
Jul. 24, 2012 |
Sep. 30, 2016 |
|
Phase 1 Clinical Trial of a licensed product [Member] | ||
Summary of milestone payment | ||
Milestones payments | $ 750,000 | $ 750,000 |
Phase 2 Clinical Trial of a licensed product [Member] | ||
Summary of milestone payment | ||
Milestones payments | 750,000 | |
Phase 3 Clinical Trial of a licensed product [Member] | ||
Summary of milestone payment | ||
Milestones payments | 1,500,000 | |
Biological License Application filing with U.S. FDA [Member] | ||
Summary of milestone payment | ||
Milestones payments | 1,750,000 | |
First commercial sale [Member] | ||
Summary of milestone payment | ||
Milestones payments | 1,500,000 | |
After first net sales [Member] | ||
Summary of milestone payment | ||
Milestones payments | $ 1,500,000 |